Related references
Note: Only part of the references are listed.Identification of antigens presented by MHC for vaccines against tuberculosis
Paulo Bettencourt et al.
NPJ VACCINES (2020)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
Lishay Parhi et al.
NATURE COMMUNICATIONS (2020)
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Chengcheng Jin et al.
CELL (2019)
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme et al.
CELL (2019)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Margaret L. Axelrod et al.
CLINICAL CANCER RESEARCH (2019)
Melanoma-related changes in skin microbiome
Jakub Mrazek et al.
FOLIA MICROBIOLOGICA (2019)
UniProt: a worldwide hub of protein knowledge
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Tumor-infiltrating BRAF(V600E)-specific CD4(+) T cells correlated with complete clinical response in melanoma
Joshua R. Veatch et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Smruti Pushalkar et al.
CANCER DISCOVERY (2018)
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21
Yongzhi Yang et al.
GASTROENTEROLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Susan Bullman et al.
SCIENCE (2017)
Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
Jin Hai Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia
Julia L. Drewes et al.
NPJ BIOFILMS AND MICROBIOMES (2017)
Learning from the Proteasome How To Fine-Tune Cancer Immunotherapy
Nathalie Vigneron et al.
TRENDS IN CANCER (2017)
Systemic Immunity Is Required for Effective Cancer Immunotherapy
Matthew H. Spitzer et al.
CELL (2017)
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
Douglas B. Johnson et al.
NATURE COMMUNICATIONS (2016)
Solid tumors provide niche-specific conditions that lead to preferential growth of Salmonella
Cecilia A. Silva-Valenzuela et al.
ONCOTARGET (2016)
The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease
Tina J. Hieken et al.
SCIENTIFIC REPORTS (2016)
M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
Marie Genin et al.
BMC CANCER (2015)
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
Chamutal Gur et al.
IMMUNITY (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria
Naama Geva-Zatorsky et al.
NATURE MEDICINE (2015)
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes
Diego Chowell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2013)
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Mauro Castellarin et al.
GENOME RESEARCH (2012)
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Aleksandar D. Kostic et al.
GENOME RESEARCH (2012)
Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients
Andrea Anichini et al.
CANCER RESEARCH (2006)
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
MR Bernsen et al.
BRITISH JOURNAL OF CANCER (2003)
Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells
M Esen et al.
APOPTOSIS (2001)
Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter
V Deffrennes et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
